Aegon Ltd. (A1EG34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 19 Oct 2026
Key indicators
| Last close | BRL 41.36 |
|---|---|
| 52-week range | 32.24 – 48.63 |
| Return, 1 month / 3 months | −12.3% / −8.4% |
| Return, 1 year / 3 years | +1.3% / +96.5% |
| Trend | Below its 200-day average |
| RSI (14) | 31 |
| Volatility (1 year) | 33.3% |
| Worst drawdown (1 year) | -21.8% |
| Average daily value traded | 0.01M BRL |
| Dividend yield | 5.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Aegon is an international insurance and asset management company based in the Netherlands. It offers life insurance, pensions, savings and investment products to individual customers and to institutions such as employers and pension funds. The company operates across Europe, the Americas and Asia, combining insurance protection with long-term savings and retirement solutions. Its business brings together insurance underwriting with the management of investment portfolios for policyholders and clients.
Aegon Ltd. is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code A1EG34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Aegon Ltd. (A1EG34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 41.36 on 19 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 580 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.3% and over the last three months it fell 8.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.0% | ||
| From 52-week high | -14.7% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -8.4% | ||
| 6-month return | 8.8% | ||
| 12-month return, skipping the last month | 15.4% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.8% | ||
| Liquidity | 31 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M BRL | ||
| Zero-volume days | 16.7% | ||
| Income | 51 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.2% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.0% |
|---|---|
| 1 month | −12.3% |
| 3 months | −8.4% |
| 6 months | +8.8% |
| 1 year | +1.3% |
| 3 years | +96.5% |
| 5 years | – |
Signals
| 50-day / 200-day average | 45.76 / 41.37 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.60 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Sep 2026 | EUR 1.0756 |
| 12 Jun 2026 | EUR 1.0576 |
| 3 Sep 2025 | EUR 1.0067 |
| 16 Jun 2025 | EUR 1.0183 |
| 4 Sep 2024 | EUR 0.8173 |
| 14 Jun 2024 | EUR 0.7966 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.